Immunoliposomes that optimize internalization into target cells
First Claim
Patent Images
1. An immunoliposome that is internalizd into a cell bearing a HER2 growth factor receptor, said immunoliposome comprising:
- a recombinantly produced antibody fragment specifically binding to the HER2 receptor said fragment attached to a polyethylene glycol derivatized lipid, an amphipathic vesicle-forming lipid, said vesicle-forming lipid forming a liposome;
a polyethylene glycol derivatized lipid;
wherein when said immunoliposome is contacted with said cell, said immunoliposome is internalized into the cell.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides for immunoliposomes that optimizes internalization of a drug into target cells bearing a characteristic cell surface marker. The immunoliposomes comprise an Fab′ domain of an antibody that specifically binds the characteristic marker, an amphipathic vesicle-forming lipid, and a polyethylene glycol derivatized lipid. The invention also provides for growth-inhibiting immunoliposomes that lack growth-inhibiting therapeutic agents and yet are capable of inhibiting the growth and proliferation of target cells.
101 Citations
9 Claims
-
1. An immunoliposome that is internalizd into a cell bearing a HER2 growth factor receptor, said immunoliposome comprising:
-
a recombinantly produced antibody fragment specifically binding to the HER2 receptor said fragment attached to a polyethylene glycol derivatized lipid, an amphipathic vesicle-forming lipid, said vesicle-forming lipid forming a liposome;
a polyethylene glycol derivatized lipid;
wherein when said immunoliposome is contacted with said cell, said immunoliposome is internalized into the cell. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
the antibody fragment is attached to the distal terminus of PEG derivatized distearoylphosphatidylethanolamine (DSPE).
-
-
9. The immunoliposome of claim 8 wherein the antibody fragment is a fab′
- .
Specification